Pathalys Pharma Competitors and Similar CompaniesClear all
Pathalys Pharma's competitors and similar companies include Lava Therapeutics, Quellis Biosciences and Design Therapeutics.
 Pathalys Pharma Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions. |  Lava Therapeutics Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies. |  Quellis Biosciences Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. |  Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. | |
Founding Date | Founding Date 2021 | Founding Date 2016 | Founding Date 2017 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Raleigh, US HQ Fujisawa, JP | Locations Utrecht, NL HQ Philadelphia, US | Locations Boston, US HQ | Locations Carlsbad, US HQ |
Employees | Employees 13 | Employees 34 | Employees N/A | Employees 54 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 53.4 m | Valuation ($) N/A | Valuation ($) 313.1 m |
Financial | ||||
Net income | Net income N/A | Net income ($25.1m) (FY, 2024) | Net income N/A | Net income ($69.8m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 150m | Total funding raised $ 102.8m | Total funding raised $ 17m | Total funding raised $ 45m |
For sources of this data, please see the company profile
View Company Profiles
Lava Therapeutics
HQ
Utrecht, NL
Employees
34
Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies.
View companyQuellis Biosciences
HQ
Boston, US
Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases.
View companyDesign Therapeutics
HQ
Carlsbad, US
Employees
54
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View company